| Value | ₹15.49 Cr |
|---|---|
| Execution period | 12 months |
BSE filing, NSE: BIJHANS. Summary written from the filing by ALFA Finder's alert engine.
Arvaya Healthcare Ltd: key numbers
- Share price
- ₹108.95
- Market cap
- ₹523.2 Cr
- Revenue (annual)
- ₹9.11 Cr
- Net profit (annual)
- ₹0.70 Cr
- P/E (TTM)
- 339.4×Sector 43.1×
- Promoter holding
- 30.62%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Arvaya Healthcare Ltd
All →Arvaya Healthcare Preferential Issue
Director Bidari Kotresh Anilkumar acquired 591,129 Arvaya Healthcare shares through a preferential offer. Holding rises to 4.45% from 3.58%.
Arvaya Healthcare Preferential Issue
Arvaya Healthcare allotted 38,71,854 equity shares at Rs.40 each to 47 SIGPL shareholders in a share swap. The allotment is valued at Rs.15.49 Crore.
- Value
- ₹15.49 Cr
Arvaya Healthcare Board Meeting Date
Arvaya Healthcare will hold a board meeting on October 24, 2026, to consider a preferential allotment of 38.72 lakh equity shares to SIGPL shareholders.
Arvaya Healthcare Other Announcement
Arvaya Healthcare Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Listing Regulations.
Arvaya Healthcare Preferential Issue
Arvaya Healthcare received BSE in-principle approval to issue 38,71,854 equity shares at Rs. 40 each. This preferential allotment totals Rs. 15.49 Crore.
- Value
- ₹15.49 Cr
Arvaya Healthcare Annual General Meeting
Arvaya Healthcare Limited held its 41st Annual General Meeting on 21st September 2026, where members adopted financial statements and approved material related party transactions.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr